Investigation of Some Immunological Markers in Covid-19 Vaccinated Individuals: A Review Article

  • Sulaiman M. Hasan Collage of Dentistry, Al-Farahidi University, IRAQ
Keywords: COVID pandemic, virus, immunological markers, vaccinated

Abstract

The COVID 19 pandemic has caused great havoc amongst the people in society across the globe. It has affected people both physically and emotionally. The epicentre of the virus has been attributed to Wuhan, from where it spread in the different parts of the globe. Vaccination emerged as one of the best solutions to deal with the proliferation of the virus. It also helped people to protect themselves against hospitalization and reduced death rates. The researcher has used Secondary sources to gather information and data related to the immunological markers in Covid-19 vaccinated population. A major immune marker is the manufacturing of neutralizing antibodies. However, the further implication in this aspect is still under research by scientists.

Downloads

Download data is not yet available.

References

[1] Adhikari, E. H., & Spong, C. Y. (2021). COVID-19 vaccination in pregnant and lactating women. Jama, 325(11), 1039-1040. https://jamanetwork.com/journals/jama/article-abstract/2776449
[2] Al‐Amer, R., Maneze, D., Everett, B., Montayre, J., Villarosa, A. R., Dwekat, E., & Salamonson, Y. (2021). COVID‐19 vaccination intention in the first year of the pandemic: A systematic review. Journal of Clinical Nursing. https://onlinelibrary.wiley.com/doi/abs/10.1111/jocn.15951
[3] Amato, M., Werba, J. P., Frigerio, B., Coggi, D., Sansaro, D., Ravani, A., ... & Baldassarre, D. (2020). Relationship between influenza vaccination coverage rate and COVID-19 outbreak: an Italian ecological study. Vaccines, 8(3), 535. https://www.mdpi.com/828936
[4] Bagcchi, S. (2021). The world's largest COVID-19 vaccination campaign. The Lancet. Infectious Diseases, 21(3), 323. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906682/
[5] Bloom, B. R., Nowak, G. J., & Orenstein, W. (2020). “When will we have a vaccine?”—Understanding questions and answers about Covid-19 vaccination. New England Journal of Medicine, 383(23), 2202-2204. https://www.nejm.org/doi/full/10.1056/NEJMp2025331
[6] Bramer, C. A., Kimmins, L. M., Swanson, R., Kuo, J., Vranesich, P., Jacques‐Carroll, L. A., & Shen, A. K. (2020). Decline in child vaccination coverage during the COVID‐19 pandemic—Michigan Care Improvement Registry, May 2016‐May 2020. American Journal of Transplantation, 20(7), 1930. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7361263/
[7] Callaway, E. (2021). Scientists identify long-sought marker for COVID vaccine success. Nature (Lond.). https://www.nature.com/articles/d41586-021-01778-2
[8] Christie, A., Brooks, J. T., Hicks, L. A., Sauber-Schatz, E. K., Yoder, J. S., Honein, M. A., ... & Team, R. (2021). Guidance for implementing COVID-19 prevention strategies in the context of varying community transmission levels and vaccination coverage. Morbidity and Mortality Weekly Report, 70(30), 1044. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323553/
[9] Curtis, N., Sparrow, A., Ghebreyesus, T. A., & Netea, M. G. (2020). Considering BCG vaccination to reduce the impact of COVID-19. The Lancet, 395(10236), 1545-1546. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31025-4/fulltext
[10] Dagan, N., Barda, N., Kepten, E., Miron, O., Perchik, S., Katz, M. A., ... & Balicer, R. D. (2021). BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. New England Journal of Medicine, 384(15), 1412-1423. https://www.nejm.org/doi/full/10.1056/nejmoa2101765
[11] Dayal, D., & Gupta, S. (2020). Connecting BCG vaccination and COVID-19: additional data. https://europepmc.org/article/ppr/ppr147103
[12] DeRoo, S. S., Pudalov, N. J., & Fu, L. Y. (2020). Planning for a COVID-19 vaccination program. Jama, 323(24), 2458-2459. https://jamanetwork.com/journals/jama/article-abstract/2766370
[13] Diesel, J., Sterrett, N., Dasgupta, S., Kriss, J. L., Barry, V., Esschert, K. V., ... & Barbour, K. E. (2021). Covid-19 vaccination coverage among adults—united states, december 14, 2020–may 22, 2021. Morbidity and Mortality Weekly Report, 70(25), 922. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc8224863/
[14] Dodd, R. H., Pickles, K., Nickel, B., Cvejic, E., Ayre, J., Batcup, C., ... & McCaffery, K. J. (2021). Concerns and motivations about COVID-19 vaccination. The Lancet. Infectious Diseases, 21(2), 161. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7832277/
[15] French, J., Deshpande, S., Evans, W., & Obregon, R. (2020). Key guidelines in developing a pre-emptive COVID-19 vaccination uptake promotion strategy. International journal of environmental research and public health, 17(16), 5893. https://www.mdpi.com/797540
[16] Gilbert, P. B., Montefiori, D. C., McDermott, A., Fong, Y., Benkeser, D. C., Deng, W., ... & Team, C. E. C. (2021). Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy trial. medRxiv. https://www.medrxiv.org/content/10.1101/2021.08.09.21261290.abstract
[17] Grech, V., & Borg, M. (2020). Influenza vaccination in the COVID-19 era. Early Human Development, 148, 105116. https://www.sciencedirect.com/science/article/pii/S0378378220303455
[18] Hegarty, P. K., Kamat, A., Zafirakis, H., & Dinardo, A. (2020). BCG vaccination may be protective against Covid-19. preprint, 10. https://sostelemedicina.ucv.ve/covid19/manuales/La%20vacuna%20BCG%20puede%20proteger%20contra%20Covid-19.pdf
[19] Hughes, M. M., Wang, A., Grossman, M. K., Pun, E., Whiteman, A., Deng, L., ... & Toblin, R. L. (2021). County-level COVID-19 vaccination coverage and social vulnerability—United States, December 14, 2020–March 1, 2021. Morbidity and Mortality Weekly Report, 70(12), 431. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993557/
[20] Hürlimann, C. (2019). Research Philosophy and Ethics. In Valuation of Renewable Energy Investments (pp. 111-126). Springer Gabler, Wiesbaden.https://link.springer.com/chapter/10.1007/978-3-658-27469-6_3
[21] Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020). Immunological considerations for COVID-19 vaccine strategies. Nature Reviews Immunology, 20(10), 615-632. https://www.nature.com/articles/s41577-020-00434-6?source=content_type%3Areact%7Cfirst_level_url%3Aarticle%7Csection%3Amain_content%7Cbutton%3Abody_link
[22] Jin, P., Li, J., Pan, H., Wu, Y., & Zhu, F. (2021). Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need. Signal Transduction and Targeted Therapy, 6(1), 1-6. https://www.nature.com/articles/s41392-021-00481-y
[23] Khubchandani, J., Sharma, S., Price, J. H., Wiblishauser, M. J., Sharma, M., & Webb, F. J. (2021). COVID-19 vaccination hesitancy in the United States: a rapid national assessment. Journal of Community Health, 46(2), 270-277. https://link.springer.com/article/10.1007/s10900-020-00958-x
[24] Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., ... & Kim, R. J. (2021). Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA cardiology. https://jamanetwork.com/journals/jamacardiology/article-abstract/2781602
[25] Kreps, S., Prasad, S., Brownstein, J. S., Hswen, Y., Garibaldi, B. T., Zhang, B., & Kriner, D. L. (2020). Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA network open, 3(10), e2025594-e2025594. https://jamanetwork.com/journals/jamanetworkopen/article-abstract/2771872
[26] Kwok, K. O., Li, K. K., Wei, W. I., Tang, A., Wong, S. Y. S., & Lee, S. S. (2021). Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey. International journal of nursing studies, 114, 103854. https://www.sciencedirect.com/science/article/pii/S002074892030345X
[27] Li, Q., Tang, B., Bragazzi, N. L., Xiao, Y., & Wu, J. (2020). Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability. Mathematical biosciences, 325, 108378. https://www.sciencedirect.com/science/article/pii/S0025556420300638
[28] Loomba, S., de Figueiredo, A., Piatek, S. J., de Graaf, K., & Larson, H. J. (2021). Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nature human behaviour, 5(3), 337-348. https://www.nature.com/articles/s41562-021-01056-1
[29] Mallapaty, S. (2021). Scientists zero in on long-sought marker of COVID-vaccine efficacy. Nature (Lond.). https://www.nature.com/articles/d41586-021-01372-6
[30] Miller, A., Reandelar, M. J., Fasciglione, K., Roumenova, V., Li, Y., & Otazu, G. H. (2020). Correlation between universal BCG vaccination policy and reduced mortality for COVID-19. MedRxiv. https://www.medrxiv.org/content/10.1101/2020.03.24.20042937v2.abstract
[31] Miyasaka, M. (2020). Is BCG vaccination causally related to reduced COVID‐19 mortality?. EMBO molecular medicine, 12(6), e12661. https://www.embopress.org/doi/abs/10.15252/emmm.202012661
[32] Moore, S., Hill, E. M., Tildesley, M. J., Dyson, L., & Keeling, M. J. (2021). Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. The Lancet Infectious Diseases, 21(6), 793-802. https://www.bmj.com/content/371/bmj.m4704.short
[33] Müller, L., Andrée, M., Moskorz, W., Drexler, I., Walotka, L., Grothmann, R., ... & Schaal, H. (2021). Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination. MedRxiv. https://www.medrxiv.org/content/10.1101/2021.03.03.21251066v1.abstract
[34] Nguyen, K. H., Srivastav, A., Razzaghi, H., Williams, W., Lindley, M. C., Jorgensen, C., ... & Singleton, J. A. (2021). COVID‐19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination—United States, September and December 2020. https://onlinelibrary.wiley.com/doi/abs/10.1111/ajt.16560
[35] Oldenburg, J., Klamroth, R., Langer, F., Albisetti, M., von Auer, C., Ay, C., ... & Greinacher, A. (2021). Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH. Hämostaseologie. https://www.thieme-connect.com/products/ejournals/html/10.1055/a-1469-7481
[36] Painter, E. M., Ussery, E. N., Patel, A., Hughes, M. M., Zell, E. R., Moulia, D. L., ... & Messonnier, N. E. (2021). Demographic characteristics of persons vaccinated during the first month of the COVID-19 vaccination program—United States, December 14, 2020–January 14, 2021. Morbidity and mortality weekly report, 70(5), 174. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7861480/
[37] PALCA, J. (2021). NPR Cookie Consent and Choices. Retrieved 2 September 2021, from https://www.npr.org/sections/health-shots/2021/08/23/1029827996/new-evidence-points-to-antibodies-as-a-reliable-indicator-of-vaccine-protection
[38] Peretti-Watel, P., Seror, V., Cortaredona, S., Launay, O., Raude, J., Verger, P., ... & Ward, J. K. (2020). A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. The Lancet Infectious Diseases, 20(7), 769-770. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30426-6/fulltext?dgcid=hubspot_email_newsletter_tlcoronavirus20&utm_campaign=tlcoronavirus20&utm_source=hs_email&utm_medium=email&utm_content=88296112&_hsenc=p2ANqtz-8eC86lN3-fEpIrv4BAQBOcyzkLUPq5g_OHEXRx4X5CXiCbGOuLnefu11o785NM9fwG7BHAwhTTak7iRdzJ83JUMRNuGQ&_hsmi=88296112
[39] Phelan, A. L. (2020). COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges. The Lancet, 395(10237), 1595-1598. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31034-5/fulltext?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news
[40] Pogue, K., Jensen, J. L., Stancil, C. K., Ferguson, D. G., Hughes, S. J., Mello, E. J., ... & Poole, B. D. (2020). Influences on attitudes regarding potential COVID-19 vaccination in the United States. Vaccines, 8(4), 582. https://www.mdpi.com/846570
[41] Ravichandran, S., Lee, Y., Grubbs, G., Coyle, E. M., Klenow, L., Akasaka, O., ... & Khurana, S. (2021). Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution. Science Advances, 7(10), eabf2467. https://advances.sciencemag.org/content/advances/7/10/eabf2467.full.pdf
[42] Ribas, A., Sengupta, R., Locke, T., Zaidi, S. K., Campbell, K. M., Carethers, J. M., ... & D'Souza, G. (2021). Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited. Cancer discovery, 11(2), 233-236. https://cancerdiscovery.aacrjournals.org/content/11/2/233.
[43] Rinott, E., Youngster, I., & Lewis, Y. E. (2021). Reduction in COVID-19 patients requiring mechanical ventilation following implementation of a national COVID-19 vaccination program—Israel, December 2020–February 2021. Morbidity and Mortality Weekly Report, 70(9), 326. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948930/
[44] Ruggiano, N., & Perry, T. E. (2019). Conducting secondary analysis of qualitative data: Should we, can we, and how?. Qualitative Social Work, 18(1), 81-97.https://journals.sagepub.com/doi/abs/10.1177/1473325017700701
[45] Sadarangani, M., Marchant, A., & Kollmann, T. R. (2021). Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nature Reviews Immunology, 1-10. https://www.nature.com/articles/s41577-021-00578-z
[46] Saxena, S., Skirrow, H., & Bedford, H. (2020). Routine vaccination during covid-19 pandemic response. https://www.bmj.com/content/369/bmj.m2392.short
[47] Sharma, A., Sharma, S. K., Shi, Y., Bucci, E., Carafoli, E., Melino, G., ... & Das, G. (2020). BCG vaccination policy and preventive chloroquine usage: do they have an impact on COVID-19 pandemic?. Cell death & disease, 11(7), 1-10. https://www.nature.com/articles/s41419-020-2720-9
[48] Shaw, R. H., Stuart, A., Greenland, M., Liu, X., Van-Tam, J. S. N., & Snape, M. D. (2021). Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data. The Lancet, 397(10289), 2043-2046. https://www.thelancet.com/journals/lancet/article/PIIS0140-67362101115-6/fulltext
[49] Sherman, S. M., Smith, L. E., Sim, J., Amlôt, R., Cutts, M., Dasch, H., ... & Sevdalis, N. (2021). COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Human vaccines & immunotherapeutics, 17(6), 1612-1621. https://www.tandfonline.com/doi/abs/10.1080/21645515.2020.1846397
[50] Sidiq, K. R., Sabir, D. K., Ali, S. M., & Kodzius, R. (2020). Does early childhood vaccination protect against COVID-19?. Frontiers in molecular biosciences, 7, 120. https://www.frontiersin.org/articles/10.3389/fmolb.2020.00120/full
[51] Speer, C., Göth, D., Benning, L., Buylaert, M., Schaier, M., Grenz, J., ... & Klein, K. (2021). Early humoral responses of hemodialysis patients after COVID-19 vaccination with BNT162b2. Clinical Journal of the American Society of Nephrology, 16(7), 1073-1082. https://cjasn.asnjournals.org/content/16/7/1073.abstract
[52] Sun, J., Zhuang, Z., Zheng, J., Li, K., Wong, R. L. Y., Liu, D., ... & Zhao, J. (2020). Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment. Cell, 182(3), 734-743. https://www.sciencedirect.com/science/article/pii/S0092867420307418
[53] Taylor, S., Landry, C. A., Paluszek, M. M., Groenewoud, R., Rachor, G. S., & Asmundson, G. J. (2020). A proactive approach for managing COVID-19: the importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2. Frontiers in psychology, 11, 2890. https://www.frontiersin.org/articles/10.3389/fpsyg.2020.575950/full
[54] Van der Veldt, A. A., Oosting, S. F., Dingemans, A. M. C., Fehrmann, R. S., GeurtsvanKessel, C., Jalving, M., ... & de Vries, E. G. (2021). COVID-19 vaccination: the VOICE for patients with cancer. Nature medicine, 27(4), 568-569. https://www.nature.com/articles/s41591-021-01240-w
[55] Van Oekelen, O., Gleason, C. R., Agte, S., Srivastava, K., Beach, K. F., Aleman, A., ... & Parekh, S. (2021). Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma. Cancer Cell, 39(8), 1028-1030. https://www.cell.com/cancer-cell/pdf/S1535-6108(21)00336-6.pdf
[56] Vasileiou, E., Simpson, C. R., Shi, T., Kerr, S., Agrawal, U., Akbari, A., ... & Sheikh, A. (2021). Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. The Lancet, 397(10285), 1646-1657. https://www.sciencedirect.com/science/article/pii/S0140673621006772
[57] Verger, P., Scronias, D., Dauby, N., Adedzi, K. A., Gobert, C., Bergeat, M., ... & Dubé, E. (2021). Attitudes of healthcare workers towards COVID-19 vaccination: a survey in France and French-speaking parts of Belgium and Canada, 2020. Eurosurveillance, 26(3), 2002047. https://www.eurosurveillance.org/docserver/fulltext/eurosurveillance/26/3/eurosurv-26-3-1.pdf?expires=1611419390&id=id&accname=guest&checksum=BC4F0E8331DDBFECFDA9443DAF8AD859
[58] Walkey, A. J., Law, A., & Bosch, N. A. (2021). Lottery-based incentive in Ohio and COVID-19 vaccination rates. JAMA, 326(8), 766-767. https://jamanetwork.com/journals/jama/article-abstract/2781792
[59] Wang, J., Jing, R., Lai, X., Zhang, H., Lyu, Y., Knoll, M. D., & Fang, H. (2020). Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines, 8(3), 482. https://www.mdpi.com/809914
[60] Wood, S., & Schulman, K. (2021). Beyond politics—promoting Covid-19 vaccination in the United States. https://www.nejm.org/doi/full/10.1056/nejmms2033790
[61] Malik, A. A., McFadden, S. M., Elharake, J., & Omer, S. B. (2020). Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine, 26, 100495.
[62] Haynes, B. F., Corey, L., Fernandes, P., Gilbert, P. B., Hotez, P. J., Rao, S., ... & Arvin, A. (2020). Prospects for a safe COVID-19 vaccine. Science translational medicine, 12(568).
[63] Corey, L., Mascola, J. R., Fauci, A. S., & Collins, F. S. (2020). A strategic approach to COVID-19 vaccine R&D. Science, 368(6494), 948-950.
[64] Dagan, N., Barda, N., Kepten, E., Miron, O., Perchik, S., Katz, M. A., ... & Balicer, R. D. (2021). BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. New England Journal of Medicine, 384(15), 1412-1423.
[65] Opel, D. J., Diekema, D. S., & Ross, L. F. (2021). Should we mandate a COVID-19 vaccine for children?. JAMA pediatrics, 175(2), 125-126.
[66] García, L. Y., & Cerda, A. A. (2020). Contingent assessment of the COVID-19 vaccine. Vaccine, 38(34), 5424-5429.
[67] Paltiel, A. D., Zheng, A., & Schwartz, J. L. (2021). Speed versus efficacy: quantifying potential tradeoffs in COVID-19 vaccine deployment. Annals of internal medicine, 174(4), 568-570.
[68] Rice, S. M., Ferree, S. D., Mesinkovska, N. A., & Kourosh, A. S. (2021). The art of prevention: COVID-19 vaccine preparedness for the dermatologist. International journal of women's dermatology.
[69] Rice, S. M., Ferree, S. D., Mesinkovska, N. A., & Kourosh, A. S. (2021). The art of prevention: COVID-19 vaccine preparedness for the dermatologist. International journal of women's dermatology.
[70] Persad, G., Emanuel, E. J., Sangenito, S., Glickman, A., Phillips, S., & Largent, E. A. (2021). Public Perspectives on COVID-19 Vaccine Prioritization. JAMA network open, 4(4), e217943-e217943.
[71] Mahase, E. (2020). Covid-19: Vaccine candidate may be more than 90% effective, interim results indicate.
[72] Burgos, R. M., Badowski, M. E., Drwiega, E., Ghassemi, S., Griffith, N., Herald, F., ... & Michienzi, S. M. (2021). The race to a COVID-19 vaccine: Opportunities and challenges in development and distribution. Drugs in Context, 10.
[73] Robertson, E., Reeve, K. S., Niedzwiedz, C. L., Moore, J., Blake, M., Green, M., ... & Benzeval, M. J. (2021). Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain, behavior, and immunity, 94, 41-50.
[74] Foy, B. H., Wahl, B., Mehta, K., Shet, A., Menon, G. I., & Britto, C. (2021). Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study. International Journal of Infectious Diseases, 103, 431-438.
[75] Kwok, K. O., Li, K. K., Wei, W. I., Tang, A., Wong, S. Y. S., & Lee, S. S. (2021). Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey. International journal of nursing studies, 114, 103854.
Published
2021-09-11
How to Cite
Sulaiman M. Hasan. (2021). Investigation of Some Immunological Markers in Covid-19 Vaccinated Individuals: A Review Article. International Journal for Research in Applied Sciences and Biotechnology, 8(5), 22-31. https://doi.org/10.31033/ijrasb.8.5.4